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ALTHOUGH tumour viruses have so far not been isolated in highly purified
form, it seems likely that most ofthe material in thepartially purified preparations
obtained by repeated centrifugation and enzyme treatment (Carr and Harris,
1951; Bather, 1953) or centrifugation and protamine sulphate precipitation
(Moloney, 1955) comes only from the cytoplasm of tumour cells. It is of interest
therefore, to investigate the nucleic acid (N.A.) of such preparations using the
newer methods of extraction and chromatography that have been applied with
success to influenza virus (Ada and Perry, 1954). The presentpaperdescribes some
preliminary observations on the chemical composition and nucleic acid content
of Rous sarcoma virus concentrates and of cytoplasmic particle concentrates
from normal fowl tissues.
MATERIAL AND METHODS
Chickens from the highly susceptible inbred line ofBrown Leghorns maintained
at thisCentrewere used throughout. These birds are constantlyselected forsuscep-
tibility to Rous sarcoma cells and virus, and allow infectivity titrations to be
made in young chicks to a constant end-point. No negatives appear in any ofthe
groups preceding that inoculated with the highest active dilution. The method
of Parker and Rivers (1936) can be used to estimate the second figure in the end-
point dilution. Groups of 4 or 5 chicks were used for each serial tenfold dilution
of virus.
Preparation ofpartially purified virus and cytoplasmic particulate concentrates
Most of the preparations were made by the standard method used in previous
work (Bather, 1953) which was adapted from that originally devised by Carr and
Harris (1951). The method employs fractional centrifugation and treatment with
the enzymes trypsin and hyaluronidase. The relative centrifugal forces used
throughout were 3500 g. for 20 minutes in a swinging cup rotor for clarification
and 20,000 g. for 45 minutes in a Servall SS.1 angle head centrifuge for sedimenta-
tion of the virus and cytoplasmic particulates. On three occasions, protamine
sulphate precipitation (Moloney, 1955) was used and gave final pellets which
containedsimilar amounts of material to that obtained by thestandardprocedure
(see "Experimental "). The concentrates were transferred to weighed test-tubes
and stored in the deep-freeze until needed for further study. Infectivity titrations
were always made on a sample of suspension immediately prior to the final sedi-
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Isolation and estimation of lipid and nucleic acid
The virus or particulate concentrates were removed from the deep freeze and
dried from the frozen state in vacuo. Lipids were extracted from the dried material
with two washings of chloroform: ethanol mixture (2: 1) followed by two wash-
ings with dry ether. The residue was dried in vacuo andweighed, andlipid content
estimated by difference. The lipid extracts were pooled and in some cases the
solvents were evaporated off and phosphorus determinations made on the resi-
dues. Five determinations made on Rous virus lipids gave an average of 2.2 per
cent P with a range of 1.6-2.4 per cent. The average figure agrees closely with
that found by Claude (1939) and indicates that approximately half of the lipid
material is in the form of phospholipids. [Recent work of Moloney (1957) has
pointed up the importance of oxidized phospholipids in the inactivation of Rous
sarcoma virus.]
The lipid-free residues were extracted with 10 per cent sodium chloride at
100° C. for thirty minutes as described by Ada and Perry (1954). The residue was
centrifuged after extraction and washed twice with 10 per cent sodium chloride.
The extracts were pooled and diluted appropriately for reading in the Ultra
Violet Spectrophotometer (Unicam SP.500). Readings were made over the wave-
length range of 240-300 m/u and a standard curve was prepared using a purified
sample (Smith and Markham, 1950) ofcommercial yeast nucleic acid. The purified
yeast N.A. contained 8.16 per cent phosphorus. Blank readings were made on a
10 per cent sodium chloride extract of normal chicken plasma protein. The fit
of the corrected U.V. absorption curves of virus and particulate N.A. were very
close to that of the purified material (Fig. 1).
The salt extracted residues from three different virus preparations were further
extracted with 1 N perchloric acid at 80° C. for thirty minutes. No evidence of
residualN.A. was found in the perchloric acid extracts when examined in the U.V.
Spectrophotometer (Fig. 1).
Estimates of the amounts of N.A. in the NaCl extracts were made by apply-
ing the factor 9-7 calculated from the known proportions of bases (see "Experi-
mental ") to convert their phosphorus content to N.A. content.
Determination of the molecular proportions of nitrogenous bases in the nucleic acids
The N.A. extracted as described was precipitated from the 10 per cent NaCl
solution by the addition of two volumes of 96 per cent ethyl alcohol and a few
drops of 0.1 N HC1 to reduce the pH to approximately 2. Precipitation was
allowed to take place at 0-4° C. for at least 24 hours. The precipitates were
washed in 66 per cent, then 96 per cent ethanol and, finally, dry ether, and dried.
1.0 N HC1 was added so that the final concentration ofN.A. was about 10 mg./ml.
(usually 40-50 /1. were required) and the tubes sealed. Hydrolysis was carried
out at 100° C. for one hour. The hydrolysates were spotted on paper strips washed
according to the method of Hanes, Hird and Isherwood (1952). The strips were
usually 10-1.5 cm. wide. The hydrolyzed bases were separated by ascending
chromatography in the solvent mixture isopropanol-HCl-water (65-18-17)
(Wyatt, 1951).
The bases were located by U.V. light using a Chromatolite Fluorescence
Lamp (Scottish Instruments) and cut out, together with corresponding pieces
from a blank strip and eluted in 5 ml. 0.1 N HC1 for 24 hours. A sample of hydro-
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lyzed yeast N.A. was always run with each series of virus or particulate N.A.'s.
The concentration of each purine or pyrimidine nucleotide was estimated by its
absorption in the U.V. Spectrophotometer. Absorption at the maxima were
Wavelength mp
FIa. 1.-Ultra violet absorption curves ofpurified yeast R.N.A., partially purified Rous virus
R.N.A. and perchloric acid extract of salt extracted Rous virus preparation.
* * Partially purified Rous virus R.N.A.
O-- - -O Purified yeast R.N.A.
x - - - x Perchloride acid extract of salt extracted Rous virus preparations.
determined for 10-3 M solutions or each ofthe purine bases andpyrimidine nucleo-
tides using pure preparations (Light & Co.).
The values obtained were:
Guanine E250 - 11.0
Adenine E260 - 13.0
Cytidylic acid E250 12 5
Uridylic acid E260 - 10.0
Other procedures will be discussed in the experimental section concerned.
EXPERIMENTAL
Examination of the partially purified virus preparations in the electron microscope
and the analytical ultra centrifuge
Samples of the partially purified virus preparations were frequently taken
after the final sedimentation. These were resuspended in water or phosphate-
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citrate buffer at pH 6.7 and sprayed on to grids for examination in a Phillips
(25A Model) Electron Microscope or a Spinco electrically driven analytical ultra-
centrifuge.
The electron micrographs usually showed particles of a fairly uniform size
distribution. In some preparations large, diffuse spots were present which tended
to fade at high voltage and may have been free lipoid material. No attempt at
accurate measurement of the particles was made because of generally poor
contrast anduncertainty as to thetruenatureofalltheparticlespresent. However,
electron microscope examination of many of the concentrated preparations served
to confirm a reasonable uniformity of particle size within the range expected for
Rous sarcoma virus (50-100 m,t) and it was not considered feasible at the present
stage to expect more detailed information.
Rates of sedimentation of the partially purified virus preparations were deter-
mined using the Spinco ultra-centrifuge incorporating a modified Schlieren
optical system. Experiments were carried out on highly active preparations of
several concentrations between 0.05 and 0-3 per cent in 0-1 M phosphate: citrate
buffer (pH 6.7). Speeds of 12,500 r.p.m. were used.
Within experimental error the sedimentation constant was independent
of concentration and had the value of 470 x 10-13 C.G.S. units. Using the newer
value of Kahler, Bryan, Lloyd and Moloney (1954a) for the density of Rous
sarcoma virus this leads to an average diameter for the particles ofapproximately
80 m,t.
Presence of normal cell components in partially purified Rous sarcoma virus
preparations
The normal cell contaminants most likely to be present after careful selection
of viable tumour tissues are from blood, muscle fibres and, possibly, connective
tissue cells. The author has observed that muscle cells yield only about 1/10
as much concentrated cytoplasmic material as tumour. Red blood cells contain
little of this type of particle in their cytoplasm. White cells and lymphocytes
may be expected to yield a considerable amount of cytoplasmic concentrate
as is evident from the results for spleen (" Experimental" Section 4) but the
numbers of these cells present must be small. There remains the possibility that,
since Rous sarcoma is ofconnective tissue origin, there may remain in the tumour
cells cytoplasmic material derived from normal connective tissue cells, which
may contribute particles to the virus concentrates. Attempts were made to
isolateacytoplasmicparticle concentrate from cock's comb, a tissue that is almost
entirely composed ofconnective tissue cells. Microscopically, comb tissue presents
a picture reminiscent ofspindle-cell sarcoma with whorling bundles of connective
tissue cells and, like the avian virus-induced tumours, yields considerable amounts
of mucoid material which is degraded by hyaluronidase. As much as 48 g. of
pooled comb tissue were homogenized and extracted in the same way as tumour
tissue. The amount of concentrated material in the final pellet was minute and
difficult to disperse. It was found to consist almost entirely of collagen fibres
whose characteristic banded structure was clearly seen in the electron microscope.
It is clear, then, that any contribution by normal particles to the virus concen-
trates must be very small and even a figure of 1 per cent is probably too high.
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Identification of the purine-bound sugar in the nucleic acid of partially purified
Rous virus preparations
Three Rous virus concentrate preparations were analysed for the presence
of deoxyribose by the method of Webb and Levy (1955) using p-nitrophenyl-
hydrazine. No deoxyribose was detected despite the reported high sensitivity of
this reagent.
The purine-bound sugar was released from partially purified Rous virus
nucleic acid (prepared as described in "Methods ") by digestion of approximately
500 ,tg. N.A. in 0.25 ml. normal H2S04 in a sealed tube at 100° C. for one hour.
The hydrolysate was neutralized with saturated Ba(OH)2 and the supernatant
evaporated to dryness. The resulting residue was extracted with hot 96 per cent
ethanol and the extract evaporated to a small enough quantity for convenient
spotting for paper chromatography. Two solvent systems were used, namely
phenol and butanol-acetic acid. The isolated sugar was chromatographed with
pure ribose, xylose and arabinose. In three experiments the purine-bound sugar
from Rous virus concentrates corresponded in RF value with pure ribose. No
deoxyribose or other purine sugar was evident.
Lipid and ribonucleic acid content of partially purified Rous virus preparations
and normal cytoplasmic particulate concentrates
Lipids andnucleic acidswereisolated andestimated asdescribedin" Methods".
The results are listed in Table I. The first set of values for Rous sarcoma are for
concentrates prepared by the standard fractional centrifugation-enzyme digestion
procedure described in the "Methods ". The second set are for concentrates
prepared as described by Moloney (1955) using protamine sulphate precipitation.
TABLE I.-Lipid and Ribonucleic Acid Content of Partially Purified Rous Sarcoma
Virus Preparations and Cytoplasmic Particulate Concentrates from Spleen,
Liver and Brain
Virus and
particulate Range of
yields Per cent Per cent infectivity
mg./g. lipid R.N.A. (M.I.D./g.
Tissue of origin Observations wet tissue ± S.D. + S.D. tumour)
Rous sarconma(1) . 38 . 051 . 42-5 . 1.42 101.2-106.5
±9.0 ±0.37
Rous sarcoma (2) . 3 . 0 54 . 43.6* . 0-78* . 102.5-104.s
(37.2-50.0) (0.92-0.64)
Spleen . . 4 . 7.04 . 36-5 . 1-02
±4-0 - 0.10
Liver . . . 5 . 4-60 . 37.6 . 0.61
±4-7 ±0.14
Brain . . . 2 . 596 . 316 . 044
(32.7-30*4) (0.42-0.46)
*Two determinations only.
Both sets of results are comparable, although the nucleic acid content is low in
the protamine sulphate preparations. However, there is a wide variation in the
R.N.A. content oftumour extracts prepared by either method (0.64-2 12percent)
andthis may be a reflection of the variation in infectivity of the different prepara-
tions. The range of infectivities available is not sufficient, as yet, to show whether
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or not a correlation exists with R.N.A. content of the type found for influenza
virus (Ada and Perry, 1956). Liver and brain concentrates appear to have a lower
average content ofR.N.A. compared with Rous virus concentrates, brain showing
the lowest. This could be due to the lesser activity of these tissues metabolically
(especially in the case of brain) assuming that R.N.A. is intimately concerned in
growth and cell division.
Molecularproportions of nitrogenous bases in ribonucleic acidfrom various sources
Ribonucleic acid isolated from partially purified virus preparations and normal
cell particulate concentrates was hydrolyzed and chromatographed as described
in the "Methods ". The molecular proportions, referred to Adenine as 1-00,
were calculated from the U.V. absorption data ofthe eluted paper strips (Table II).
TABLE II.-Molecular Proportions of Purine and Pyrimidine Bases obtained by
Chromatographic Separation on Filter Paper ofR.N.A. from Yeast, Partially
Purified Rous sarcoma Virus Preparations and Cytoplasmic Concentrates of
Fowl Liver and Spleen
Source Number A + U Pu. A + C
of of Guanine Cytosine Uracil G + C Py. G + U
R.N.A. obs. Adenine i S.D. ± S.D. ± S.D. i S.D. ± S.D. i S.D.
Yeast . 7 1.00 1.-15 0-82 0-88 0-96 1-27 0 89
±0 04 ±0-01 ±0-02 ±0-02 0- 03 ±0-02
Rous 6 1.00 1.80 1.55 0-81 0-54 1-20 0-98
sarcoma ±0-08 ±0-03 i0-07 ±0-03 4±0-04 ±0'03
Spleen . 4 1.00 1-98 1-54 0-81 0-52 1-27 0-92
±0-11 i0- 13 ±0-08 ±0-01 ±0 05 ±0.06
Liver . 2 1.00 1-81 1-58 0- 71 0.50 1-22 1-02
(1-78-1 - 84) (1-62-1 - 54) (0 67-0 75) (0 49-0 52) (1-22-1 -24) (1-07-0 -98)
R.N.A. from Rous sarcoma concentrated extracts in common with that
from spleen and liver, contains a large proportion of both guanine and cytosine.
Such a preponderance of these two bases has been found in most ribonucleic
acids studied with the exception of yeast and influenza virus R.N.A. (Elson and
Chargaff, 1954; Ada and Perry, 1954, 1956). No significant differences have
appeared in the ratios of adenine + uracil between Rous virus concentrate and guanine + cytosine
spleen and liver R.N.A. when subjected to the t-test at the 1 per cent level. The
finacolmnladenine +] cytosi~~' ndiae final column guine+ urcytos ne indicates that in all cases the number of guanine + uracil
6-keto groups is nearly equal to the number of 6-amino groups and is of interest
inrelation to thepossible configuration of theR.N.A. molecule (ElsonandChargaff,
1954).
DISCUSSION
Previous estimates of the nucleic acid content of partially purified Rous virus
concentrates were made by Claude (1939), who gave a value of 5-8 per cent
of the total virus material as N.A., and by Shemin and Sproule (1942) who esti-
mated the N.A. as approximately 1-5 per cent. The former based his values on
U.V. absorption methods while the latter used purine nitrogen values. The
experiments described here show that Rous virus concentrate R.N.A. can be
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extracted completely and in a relatively pure form with10 per cent NaCl and
that the amounts so obtained vary considerably between a minimum of0.64
per cent and a maximum of2.12 per cent of the total virus concentrate. Claude
did not use trypsin digestion to further purify his material and it may be that the
high value found was because of this.
Recent reports from Kahler et al. (1954a, b) have placed the density of Rous
virus atapproximately 1415 orlower and the diameter at 90m/t. The data presented
here indicate that the great majority of the particles in the partially purified
virus preparations, with which almost all the infectivity is associated, are of fairly
uniform size and density, as far as can be ascertained with the electron microscope
and the analytical ultracentrifuge. Their diameter in these experiments was
calculated as approximately 80 m/t. The molecular weight of the Rous virus
particle has been estimated to be approximately 140 x 106 (Claude, 1937).
The values for R.N.A. content given in this paper show that Rous sarcoma virus
fits in with the relationship pointed out by Frisch-Niggemeyer (1956) and Cheng
(1957), namely that most R.N.A. containing viruses and cytoplasmic particles
appear to contain the same absolute amount of R.N.A. (approximately 2 x 106
g. per mole of virus or particle).
No differences in the molecular proportions of purine and pyrimidine bases
occurred between partially purified preparations ofRous virus and the cytoplasmic
particulate concentrates of the normal tissues studied. The question of purity is,
of course, ever present in tumour virus work and it may be argued that most of the
nucleic acid came from non-tumour sources. It can be said, however, that normal
cell components must be present in very small amounts in virus concentrates
prepared in this way. The fact that no D.N.A. can be detected in the preparations
makes improbable contamination by nuclear material. Non-virus protein contami-
nants are removed to a large extent by trypsin treatment. We are left, then, with
a suspension of cytoplasmic particles derived almost entirely from tumour cells,
a counterpart of which (cock's comb connective tissue) yields negligible quantities
of suchparticles. Thefact that the amounts of material in the high speed centrifuge
pellets are different when isolated from different tissues probably reflects the
variations in the fine structure of the cytoplasm. Palade (1955) and Palade an
Siekevitz (1956) have studied many types of cell in the electron microscope and
attempted to relate the fine structure to cytological, histochemical and cyto-
chemical information. It is not known how much of the pellet material obtained
in these experiments can be attributed to the very small (100-150A) particulates
described by Palade. If, as has been suggested, these particulates correspond to
those isolated by Petermann and co-workers by differential centrifugation (1952,
1953 and 1954) then most of them would be discarded during the isolation of the
partially purified virus and cytoplasmic particulates by the method employed
here. In any case, as Petermann and co-workers have shown that in mouse
leukaemia all their spleen cytoplasmic particulate fractions increased over the
normal picture it is probable that particles isolated along with the virus are
closely related to virus in the metabolic processes of the cell. The situation is
further complicated by the fact that only a very few particles structurally resemb-
ling virus are seen in sectioned pellets of centrifuged extracts of Rous sarcoma
(Bernhard, Oberling andVigier, 1956). No guarantee, therefore, that allthe nucleic
acid isolated from the partially purified virus preparations is from virus can be
given. It can only be said that it is intimately associated with the cytoplasmic
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particulates ofRous cells and with that fraction ofthe particulates which contains
the infective principle.
It would be interesting to see ifother virus-induced tumours yield concentrates
containing different R.N.A. from that found in Rous, and several tumours which
are now available at this Centre are being studied.
The lack of any marked difference between normal and virus nucleic acid may
not be surprising when it is remembered that tumour viruses live in a peculiarly
close symbiosis with the parent cell, usually remaining within the cell throughout
the life of the tumour. Any differences there are in nucleic acid composition,
therefore, may be so subtle as to be impossible to detect by methods such as were
employed here.
SUMMARY
The nucleic acid associated with partially purified preparations of Rous
sarcoma virus can be quantitatively extracted and estimated using 10 per cent
sodium chloride solution and ultra-violet spectrophotometry. The preparations
used consist of particles of reasonably uniform size exhibiting a sharp peak in
the analytical ultracentrifuge and having a sedimentation constant of 470 C.G.S.
units and a calculated diameter ofapproximately 80 m,t. They are almost entirely
free of normal tissue and nuclear contaminants.
The purine-bound sugar contained in the nucleic acid obtained from the Rous
sarcoma virus preparations has been identified by paper chromatography as
ribose and no evidence of deoxyribose was found by chromatography or the
p-nitrophenylhydrazine reaction.
A series of 38 Rous sarcoma virus preparations was found to contain 1.42 i
0.37 per cent R.N.A. with a range of values extending from 0.64-2.12 per cent.
The average R.N.A. content was higher than that of cytoplasmic particulate
concentrates from spleen (1.02 ± 0.10 per cent), liver (0-61 ± 0.14 per cent) and
brain (0-42-0.46 per cent).
No significant differences were found in the molecular proportions of purine
and pyrimidine bases from Rous sarcoma virus preparations or cytoplasmic
particulate concentrates from normal tissues.
All expenses in connection with this work were borne by the British Empire
Cancer Campaign. I should like to thank Dr. C. T. Greenwood of the Department
of Chemistry, King's Buildings, Edinburgh, for his co-operation in obtaining the
results with the analytical ultracentrifuge.
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